The Centers for Medicare and Medicaid Services (CMS) has finalized new MIPS Value Pathways (MVPs) that are relevant to specialties we serve. One of these is the Dermatological Care MVP, which is available for reporting in the 2025 performance year.
Although MVP reporting is currently voluntary, CMS has expressed the intention of sunsetting traditional MIPS and transitioning to MVPs entirely in the future. In the 2025 MIPS proposed rule, CMS requested feedback on the possibility of making MVPs mandatory as early as 2029.
Anatomy IT will continue to advocate for MVPs to be optional and for improvements to the Dermatological Care MVP to make it possible for all dermatologic subspecialties to be successful.
In this blog, we’ll break down what MVPs are, how to report them, and what measures and activities are included in the Dermatological Care MVP.
What is a MIPS Value Pathway (MVP)?
CMS introduced MVPs as an alternative reporting option to traditional MIPS in 2023. According to CMS, MVPs aim to simplify MIPS, reduce reporting burden, and help patients make more informed decisions when choosing their clinicians.
Each MVP has its own specific set of quality measures, improvement activities (IAs), and cost measures, and you are limited to those measures and activities when reporting the MVP. The Promoting Interoperability (PI) category is included as part of a “foundational layer,” meaning that PI requirements are the same for every MVP. Also included in the foundational layer is a population health measure, which contributes to your overall Quality score.
Can I Report an MVP Through a Registry?
Since 2023, Qualified Registries (QRs) and Qualified Clinical Data Registries (QCDRs), such as the DataDerm QCDR, have been required to support all measures in the Quality, IA, and PI categories of the MVPs relevant to their clinicians. They are not required to support the Cost category, Population Health measures, QCDR measures, or the CAHPS for MIPS Survey.
While registries must support MVPs relevant to their clients, you will only be able to report DataDerm QCDR measures through DataDerm.
How Are MVPs Different from Traditional MIPS?
The table below highlights the differences by category between reporting traditional MIPS versus reporting an MVP.
If you choose to report both traditional MIPS and an MVP, CMS will assign you the higher of the two scores.
How Do I Report an MVP?
To report an MVP for the 2025 performance year, you must register between April 1, 2025, and December 1, 2025, at 8 pm ET. Registration is available through your QPP account.
At the time of registration, you must include the following information:
- The MVP you are choosing to report,
- Any administrative claims measures you would like to be included as 1 of your 4 required Quality measures,
- Whether you are planning to count the CAHPS for MIPS Survey measure towards 1 of the 4 required Quality measures, and
- Your participation level (group, subgroup, individual, APM).*
**If you report at the group level and are part of a multispecialty group, you will be required to report at the subgroup level starting in 2026.*
If you are an Anatomy IT client, we will discuss whether to report an MVP during your kickoff call.
What Measures Are Included in the MVP for Dermatology?
Click on the category names below to see the measures and activities included in the Dermatological Care MVP.
Dermatological Care Measures (Specific to This MVP)
Dermatological Care Measures (Specific to This MVP)
- 130: Documentation of Current Medications in the Medical Record (high priority)
- 176: Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy
- 226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
- 397: Melanoma Reporting (high priority)
- 410: Psoriasis: Clinical Response to Systemic Medications (outcome)
- 440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician (high priority)
- 485: Psoriasis – Improvement in Patient-Reported Itch Severity (outcome)
- 486: Dermatitis – Improvement in Patient-Reported Itch Severity (outcome)
- 487: Screening for Social Drivers of Health (high priority)
- 503: Gains in Patient Activation Measure (PAM®) Scores at 12 Months (outcome)
- 509: Melanoma: Tracking and Evaluation of Recurrence (high priority)
- AAD6: Skin Cancer: Biopsy Reporting Time – Clinician to Patient (high priority)
- AAD8: Chronic Skin Conditions: Patient Reported Quality-of-Life (high priority)
- AAD12: Melanoma: – Appropriate Surgical Margins (outcome)
- AAD16: Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Procedures (high priority)
- AAD17: Continuation of Anticoagulation Therapy in the Office-based Setting for Closure and Reconstruction After Skin Cancer Resection Procedures (high priority)
- AAD18: Avoidance of Opioid Prescriptions for Closure and Reconstruction After Skin Cancer Resection (high priority)
- AHE_1: Enhance Engagement of Medicaid and Other Underserved Populations
- AHE_6: Provide Education Opportunities for New Clinicians
- BE_4: Engagement of patients through implementation of improvements in patient portal
- BE_6: Regularly Assess Patient Experience of Care and Follow Up on Findings
- BE_15: Engagement of patients, family and caregivers in developing a plan of care
- EPA_2: Use of telehealth services that expand practice access
- PM_16: Implementation of medication management practice improvements
- PM_26: Vaccine Achievement for Practice Staff: COVID-19, Influenza, and Hepatitis B
- PSPA_8: Use of Patient Safety Tools
- PCMH: Electronic submission of Patient Centered Medical Home accreditation
- MVP: Practice-Wide Quality Improvement in MIPS Value Pathways
- Melanoma Resection
Foundational Layer (Applies to All MVPs)
- 479: Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment Systems (MIPS) Groups
- 484: Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions
All of the following attestations and measures are required (no exclusions):
- Use of CEHRT
- Actions to Limit or Restrict Interoperability of CEHRT
- ASTP/ONC Direct Review
- High Priority SAFER Guides Assessment
- Security Risk Analysis
- Provide Patients Electronic Access to Their Health Information
All of the following measures are required (unless claiming an exclusion):
- e-Prescribing
- Query of Prescription Drug Monitoring Program (PDMP)
- Immunization Registry Reporting
- Electronic Case Reporting
One of the following options is required:
- Option 1: Support Electronic Referral Loops by Sending Health Information + Support Electronic Referral Loops by Receiving and Reconciling Health Information
Exclusions are available for both measures in this option.
You can optionally report on one (only one) of the following measures for 5 bonus points in the PI category:
- Syndromic Surveillance Reporting
- Clinical Data Registry Reporting
- Public Health Registry Reporting
Is Reporting the Dermatological Care MVP in 2025 Worth It?
Yes. CMS is considering making MVP reporting mandatory starting in 2029. That means there are only a few MIPS performance years left to find flaws, gather data, and recommend improvements before MVPs become the only way in which you can participate in MIPS and avoid a penalty. By reporting the 2025 Dermatological Care MVP, you will:
- Gain invaluable experience to prepare you for mandatory MVP reporting,
- Not negatively impact your MIPS payment adjustment as long as you also report traditional MIPS (even if you score poorly in the MVP), and
- Be able to provide real-world feedback to CMS to help them improve the MVP available to you before MVP reporting becomes mandatory. You can communicate with us to describe your experience with the MVP or you can tell CMS directly by commenting on the 2026 Medicare Physician Fee Schedule Proposed Rule this summer or by following the steps outlined here by CMS.
Next Steps
- Share this information with your colleagues.
- Subscribe to our blog to get alerts on this and other important issues. You can subscribe using the field in our website footer below.
- If you are an Anatomy IT client, contact your MIPS Expert if you have any questions.
- If you are not an Anatomy IT client, contact us to learn more about our MIPS Success Plan and to reap the rewards of our combined decades of experience.
If you have any questions on this, let us know!
**
Written By: **Sarrah Hakim, MHSA
About the Author: Sarrah is a Manager of Health Policy at Anatomy IT.